Startseite Comparison of a commercial urinary neopterin radioimmunoassay with high performance liquid chromatography
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Comparison of a commercial urinary neopterin radioimmunoassay with high performance liquid chromatography

  • Angelika Hammerer-Lercher EMAIL logo , Christina Moser , Veronika Leichtfried , Wolfgang Schobersberger , Andrea Griesmacher und Dietmar Fuchs
Veröffentlicht/Copyright: 14. Januar 2012
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: The determination of urinary neopterin using high performance liquid chromatography (HPLC) has routinely been performed in Innsbruck since the middle of the 1980s. The aim was to compare the HPLC method with a commercially available radioimmunoassay.

Methods: Neopterin to creatinine ratios were calculated in the urine of 33 healthy volunteers (33±7.3 years) collected at eight given time points. Neopterin and creatinine were simultaneously determined by HPLC and by radioimmunoassay (RIA; BRAHMS; neopterin) and an enzymatic method (Roche; creatinine), respectively. Assays were compared with Bland-Altman plots and Passing-Bablok regression analysis.

Results: Neopterin to creatinine ratios ranged from 62 to 490 μmol/mol (HPLC) and from 17 to 425 μmol/mol (RIA-enzymatic combined). The ratios were on average 17.3% lower using the combined RIA-enzymatic method compared to the HPLC method. Neopterin concentrations measured by RIA were only slightly lower (on average 4.9%) than by the HPLC and the regression analysis revealed a good accordance with linearity. In contrast, creatinine concentrations by the enzymatic method were on average 12.8% higher than by HPLC.

Conclusions: There is a marked bias between HPLC and the combined RIA-enzymatic method for measurement of urinary neopterin to creatinine ratios which has to be considered when methods are switched during the follow-up of patients.


Corresponding author: Angelika Hammerer-Lercher, MD, Central Institute of Medical and Chemical Laboratory Diagnostics University Hospital of Innsbruck Anichstraße 35, 6020 Innsbruck, Austria Phone: +43 512 504 82116, Fax: +43 512 504 2488

Received: 2011-8-24
Accepted: 2011-12-16
Published Online: 2012-01-14
Published in Print: 2012-06-01

©2012 by Walter de Gruyter Berlin Boston

Artikel in diesem Heft

  1. Masthead
  2. Masthead
  3. Editorial
  4. Laboratory maternal-fetal medicine: challenges and perspectives
  5. Reviews
  6. Candidate biochemical markers for screening of pre-eclampsia in early pregnancy
  7. Linking preeclampsia and cardiovascular disease later in life
  8. Mini Reviews
  9. Fetal nucleic acids in maternal blood: the promises
  10. Ethical aspects of the expansion of neonatal screening programme due to technological advances
  11. Prenatal screening for trisomy 21: recent advances and guidelines
  12. Ultrasound markers for the detection of women at risk of developing pre-eclampsia
  13. Are biological markers relevant for the diagnosis and the prognosis of preterm premature rupture of membranes (PPROM)?
  14. Genetics and Molecular Diagnostics
  15. Study of FTMT and ABCA4 genes in a patient affected by age-related macular degeneration: identification and analysis of new mutations
  16. Rapid detection of CFH (p.Y402H) and ARMS2 (p.A69S) polymorphisms in age-related macular degeneration using high-resolution melting analysis
  17. Unlabeled-probe high-resolution melting to detect KRAS codon 12 and 13 mutations in pancreatic adenocarcinoma tissues
  18. General Clinical Chemistry and Laboratory Medicine
  19. Volume, rates, source and types of add-on pathology test requests across five hospitals
  20. Schizophrenia is associated with increased levels of serum Fas and FasL
  21. Comparison between capillary, venous and arterial levels of protein S100B in patients with severe brain pathology
  22. Changes of serum adiponectin and soluble intercellular adhesion molecule-1 concentrations after smoking cessation
  23. Lack of consistency between two commercial ELISAs and against an in-house ELISA for the detection of CD36 in human plasma
  24. Comparison of a commercial urinary neopterin radioimmunoassay with high performance liquid chromatography
  25. Evaluation of Prevent ID and Quantum Blue rapid tests for fecal calprotectin
  26. Analytical performance evaluation of four cartridge-type blood gas analyzers
  27. Cancer Diagnostics
  28. Serum free light chains and oligoclonal bands in patients with multiple myeloma and autologous stem cell transplantation
  29. Cardiovascular Diseases
  30. Homocysteine as a determinant of left ventricular ejection fraction in patients with diabetes
  31. Plasma total homocysteine is a determinant of carotid intima-media thickness and circulating endothelial progenitor cells in patients with newly diagnosed hypertension
  32. Serum MMP-9 and TIMP-1 concentrations and MMP-9 activity during surgery-induced inflammation in humans
  33. Effects of endothelin-1 on endothelial progenitor cell function
  34. Investigation of cystatin C and cystatin C based estimated glomerular filtration rate in pregnant patients with heart failure
  35. Letters to the Editor
  36. Comments on a performance evaluation of cartridge-type blood gas analyzers
  37. Comments on a performance evaluation of cartridge-type blood gas analyzers. Reply
  38. Carryover can be a cause of false-positive results with the Beckman AccuTnI assay
  39. Method comparison of a 25-hydroxy vitamin D enzyme immunoassay to liquid chromatography tandem mass spectroscopy
  40. Bone marrow plasma cell separation – validation of separation algorithm
  41. Sharing our experience in improving postgraduate clinical biochemistry training with laboratory practice articles
Heruntergeladen am 17.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2011-0861/html
Button zum nach oben scrollen